Jeeva is grounded in deep empathy
After suffering the loss of a child to a rare congenital disorder, Jeeva founder and CEO Dr. Harsha Rajasimha applied his years of postdoctoral training in the United States at the National Institutes of Health and the U.S. Food and Drug Administration, as well as his work in the life science industry, to accelerating treatments for rare diseases by eliminating bottlenecks in the clinical trials process.
Jeeva identified travel requirements for clinical trial patients as a major barrier to recruitment and retention. The COVID-19 pandemic is accelerating the demand to decentralize the way clinical trials are conducted. Sponsors, investigators, regulators, and participants are all embracing the potential of digital technologies to reduce the cost, increase the speed, and ease the burden on participants in these studies.
The Jeeva eClinical Cloud
The human-centric software-as-a-service (SaaS) platform enabling clinical research at scale
Jeeva's eClinical cloud platform enables clinical researchers, CROs, public health organizations, health and human services, and Biotechnology, Medical Device, and Pharmaceutical sponsors to remotely recruit participants 3X faster anywhere.
Convenient & Fast
Jeeva's flexible bring your own device (BYOD) SaaS solution works on any browser-enabled mobile device & saves >70% time/logistical burden on study teams, participants, and caregivers.
Jeeva's modular software design allows a rapid study configuration with the features and workflows that fit the specific trial protocol whether the studies are short-term or long-term, cross-sectional or longitudinal, interventional or observational.